Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucocorticoids in Thyroid Associated Ophthalmopathy
NCT03107078Phase 4Unknown
- Start
- Oct 2016
- Primary completion
- Oct 2019
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of methylprednisolone injection in thyroid associated ophthalmopathy (TAO) (4 arms). Primary endpoints: Number of patients defined as Response at 2 years, Number of patients defined as Deterioration at 2 years and 1 more. Status: unknown.
02
Drugs
methylprednisolone injection
03
Conditions
thyroid associated ophthalmopathy (TAO)
Beyond the preview
Go deeper on NCT03107078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03107078.